computed tomography (CT) scan suggested new peritoneal metastases, the oncologist disagreed and pushed for more chemotherapy. I was concerned that his symptoms were related to progressive disease, but because of my now limited involvement with Mr. Cardosa's care, I felt that I was in no position to intervene.
I tried to convince myself that the oncologist should have kept me informed, but the truth was that I had let myself slide from participant to observer. Had I been more involved, the Cardosas, and perhaps, even the oncologist would have contacted me to take part in discussing the advisability of continued chemotherapy versus palliation and hospice care. My role in Mr. Cardosa's care would have been different, less central than previously, but it would still be important. The simple gesture of suggesting return visits would have allowed me to stay a functional part of the health care team and perhaps spared the couple some of the isolation and suffering they endured at the end.
Since my experiences with the Cardosas, I have begun to tell my patients newly diagnosed with serious illnesses that require subspecialty care (cancer, dialysis, and transplant) that I want to see them at intervals during their treatment and urge them to call me if they need advice. I have been struck by how positively they respond to this recommendation. I, too, feel better about my continued involvement with them.
My experience with the Cardosas brought into focus an important function of the General Internist. It made me strive to overcome concerns about status. Patients do suffer when the General Internist is not involved. We cannot afford to abandon our patients who develop serious illnesses even when subspecialists assume major responsibility for their treatment. If we do so, we deny our patients the best care; we deny ourselves the joys and sorrows of continuity; and we fail to fulfill our roles as General Internists.
